This study proposes that SHP2 may dampen lung adenocarcinoma progression by inhibiting the STAT3/STAT6 pathway in TAMs, consequently reducing M2 polarization and the secretion of factors like cathepsin, which in turn, could limit the growth and spread of lung adenocarcinoma cells. The gene discussed is STAT6; the disease is lung adenocarcinoma.